PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort

OBJECTIVE: To evaluate the polymerase chain reaction (PCR)-reverse-dot-blot (RDB) human papillomavirus (HPV) genotyping test as a feasible assay for the cervical cancer primary screening. METHODS: In a hospital-based cohort, a total of 21,568 women were voluntarily enrolled from March 2009 to Novemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yafang, Sun, Pengming, Mao, Xiaodan, Dong, Binhua, Ruan, Guanyu, Chen, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424850/
https://www.ncbi.nlm.nih.gov/pubmed/30887754
http://dx.doi.org/10.3802/jgo.2019.30.e29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424850/
https://www.ncbi.nlm.nih.gov/pubmed/30887754
http://dx.doi.org/10.3802/jgo.2019.30.e29

Ejemplares similares